Connect with us

Health and Wellness

A New COVID Vaccine Is Here: Why You Might Not Want to Rush to Get It

Published

on

COVID, COVID-19, COVID vaccine, COVID shot, vaccinations, COVID vaccinations, vaccines, Flu/COVID season, COVID season, When should I get a COVID shot, When should I get a COVID booster, COVID booster, theGrio.com

The FDA has approved an updated COVID-19 vaccine for everybody ages 6 months and up, once more presenting Americans with a dilemma: Should they get vaccinated now, as the most recent COVID-19 outbreak rages across the country, or save their shot for the winter surge?

The latest vaccine should provide some protection for everybody. But many healthy individuals who have already been vaccinated or have immunity because they’ve been exposed to COVID enough times might want to wait a couple of months.

COVID has turn into widespread. For some, it’s a light illness with few symptoms. Others lie around with fever, cough, and fatigue for days or even weeks. A much smaller group—mostly the elderly or chronically in poor health—suffer hospitalization or death.

It’s essential for high-risk people to get vaccinated, but vaccine protection wears off after a couple of months. People who rush to get the brand new vaccine may very well be at greater risk of getting sick this winter when the subsequent wave hits, said William Schaffner, a professor of infectious diseases at Vanderbilt University School of Medicine and a spokesman for the National Foundation for Infectious Diseases.

On the opposite hand, the main variants could change by late fall, making the vaccine less effective, Peter Marks, the FDA’s chief vaccine official, said at an Aug. 23 briefing. He urged everyone eligible to get vaccinated, noting that the chance of long COVID is higher amongst unvaccinated or undervaccinated people.

Of course, if last yr’s COVID-19 vaccination drive is any indication, few Americans will heed his advice, despite the fact that this yr’s surge in cases has been particularly intense and levels of the COVID-19 virus in sewage suggest infections are as common as they were last winter.

The Centers for Disease Control and Prevention is now turning to wastewater as fewer people report their test results to health officials. Wastewater data shows the outbreak is worst in Western and Southern states. In New York, for instance, levels are considered “high” — compared with “very high” in Georgia.

COVID hospitalizations and deaths are also trending upward. But unlike infections, these rates are nowhere near those seen during winter surges or in previous years. In July, greater than 2,000 people died from COVID—a big number, but a small fraction of the at the least 25,700 COVID deaths in July 2020.

Partial immunity built up through vaccines and former infections deserves credit for that relief. A latest study suggests that current variants could also be less virulent — one in every of the most recent variants within the study he didn’t kill the mouse exposed to it, unlike most previous COVID variants.

Public health officials note that even with the rise in cases this summer, people seem to be managing the illness at home. “We’ve seen a slight increase in cases, but it hasn’t had a significant impact on hospitalizations and emergency room visits,” Connecticut Public Health Commissioner Manisha Juthani said at an Aug. 21 news conference.

Unlike the flu or traditional cold viruses, COVID appears to be thriving outside of the cold months, when infected children at school, dry air and indoor activities are thought to allow airborne and saliva-borne viruses to spread. No one is certain why.

“COVID is still very contagious, it’s brand new, and in the summer, people are gathering in air-conditioned spaces,” said John Moore, a virologist and professor at Weill Cornell Medicine College at Cornell University.

“Or maybe COVID is more resistant to moisture and other environmental conditions in the summer,” said Caitlin Rivers, an epidemiologist at Johns Hopkins University.

Because viruses evolve as they infect people, the CDC has beneficial updated COVID vaccines yearly. Last fall’s booster shot was designed to goal the omicron variant circulating in 2023. This yr, mRNA vaccines from Moderna and Pfizer and a protein-based vaccine from Novavax — which has not yet been approved by the FDA — goal the newer omicron variant, JN.1.

The FDA has determined that mRNA vaccines are effective at protecting people against severe disease and death — and can proceed to say so at the same time as earlier JN.1 variants are actually being displaced by others.

Public interest in COVID-19 vaccines has waned, with just 1 in 5 adults getting a shot since last September, down from about 80% who’ve received their first dose. New Yorkers were barely above the national vaccination rate, while in Georgia, only about 17% had received their final dose.

Vaccine uptake is lower in states where a majority voted for Donald Trump in 2020, and amongst those that have less money, less education, less access to health care, or less day without work work. These groups are also more likely The risk of hospitalization or death from the disease, according to a 2023 study published in The Lancet.

While newly developed vaccines are higher targeted at circulating COVID variants, uninsured and underinsured Americans could have to hurry in the event that they want to get the vaccine free of charge. The CDC program that has provided booster shots to 1.5 million people over the past yr has exhausted funds and is ending Aug. 31.

The agency has pocketed $62 million in unspent funds to pay state and native health departments to provide latest vaccines to people without insurance. But “that may not be enough” if the vaccine costs the agency about $86 per dose, because it did last yr, said Kelly Moore, CEO of Immunize.org, which advocates for vaccinations.

People who pay out of pocket at pharmacies face higher prices: CVS plans to sell the improved vaccine for $201.99, said Amy Thibault, an organization spokeswoman.

“Price can be a barrier, access can be a barrier” to accessing vaccinations, said David Scales, an assistant professor of drugs at Weill Cornell Medical College.

Without an access program to provide vaccines to uninsured adults, “we will see disparities in health care outcomes and disproportionately high disease outbreaks among the working poor who cannot afford to take time off,” said Kelly Moore.

New York state has about $1 million to fill gaps when the CDC program ends, said Danielle De Souza, a spokeswoman for the New York State Department of Health. That will allow it to buy about 12,500 doses for uninsured and underinsured adults, she said. There are about 1 million uninsured people within the state.

Last yr, CDC and FDA experts decided to promote annual fall vaccinations against COVID and influenza, in addition to a one-time vaccination against RSV for certain groups.

It could be impractical for vaccine manufacturers to change the COVID-19 vaccine formula twice a yr, and giving three shots in a single or two doctor visits looks like the easiest way to increase the number of individuals vaccinated, according to Schaffner, who’s a consultant to the CDC’s Advisory Committee on Immunization Practices.

Featured Stories

He added that at its next meeting in October, the commission will likely appeal to people prone to infection to receive a second dose of the identical COVID-19 vaccine within the spring to protect themselves against one other wave of infections in the summertime.

If you’re in a vulnerable group and are waiting until after the vacations to get vaccinated, Schaffner said it’s value wearing a mask and avoiding large crowds, and getting tested in case you think you could have COVID. If the test comes back positive, people in these groups should seek medical attention, because the antiviral pill Paxlovid can ease symptoms and keep them out of the hospital.

For conscientious individuals who feel they might be sick and don’t want to spread COVID-19, the most effective advice is to take a single test and, if it comes back positive, try to isolate for a couple of days, then wear a mask for a couple of days while avoiding crowded spaces. Retesting after a positive result’s pointless, because virus particles can linger within the nose for days, with no risk of infecting others, Schaffner said.

The Department of Health and Human Services will make 4 free COVID-19 tests available to anyone who requests them starting in late September through the web site covidtest.gov, Dawn O’Connell, assistant secretary for preparedness and response, said at an Aug. 23 briefing.

The government is focusing its fall vaccination drive, which it has dubbed “Less Risk, More Life,” on older people and nursing home residents, HHS spokesman Jeff Nesbit said.

Not everyone may really want a fall COVID booster, but “it’s not a bad thing to give people options,” said John Moore. “A 20-year-old athlete is less at risk than a 70-year-old overweight guy. It’s that simple.”


Healthbeat is a nonprofit public health newsroom published by Citizen News Company AND KFF Health News. Sign up for his or her newsletters Here. KFF Health News is a national newsroom that produces in-depth health journalism and is one in every of the most important operating programs of KFF, an independent source of health policy research, polling and journalism. Learn more about KFF.

This article was originally published on : thegrio.com
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health and Wellness

Jury awarded $310 million to parents of teenager who died after falling on a ride at Florida amusement park – Essence

Published

on

By

Sun Sentinel/Getty Images

The family of Tire Sampson, the 14-yr-old who tragically died on an amusement park ride in Orlando, Florida, in 2022, has been awarded $310 million in a civil lawsuit.

Tire, who was visiting ICON Park along with his family on March 24, 2022, fell from the FreeFall drop tower. Although he was taken to a nearby hospital, he didn’t survive his injuries.

Now, greater than two years later, a jury has held the vehicle manufacturer, Austria-based Funtime Handels, responsible for the accident and awarded the Tire family $310 million. According to reports from local news stations WFTV AND KSDKthe jury reached its verdict after about an hour of deliberation.

Tyre’s parents will each receive $155 million, according to attorney spokesman Michael Haggard.

Attorneys Ben Crump and Natalie Jackson, who represented Tyre’s family, shared their thoughts on this landmark decision via X (formerly Twitter). “This ruling is a step forward in holding corporations accountable for the safety of their products,” they said in a statement.

Lawyers stressed that Tyre’s death was attributable to “gross negligence and a failure to put safety before profits.” They added that the ride’s manufacturer had “neglected its duty to protect passengers” and that the substantial award ensured it could “face the consequences of its decisions.”

Crump and Jackson said they hope the result will encourage change throughout the theme park industry. “We hope this will spur the entire industry to enforce more stringent safety measures,” they said. “Tire heritage will provide a safer future for drivers around the world.”

An investigation previously found that Tyre’s harness was locked through the descent, but he dislodged from his seat through the 430-foot fall when the magnets engaged. Tire’s death was ruled the result of “multiple injuries and trauma.”

ICON Park said at the time that it could “fully cooperate” with the authorities.

This article was originally published on : www.essence.com
Continue Reading

Health and Wellness

Tireless HIV/AIDS advocate A. Cornelius Baker dies

Published

on

By

HIV/AIDS Advocate, A. Cornelius Baker


A. Cornelius Baker, a tireless advocate of HIV and AIDS testing, research and vaccination, died Nov. 8 at his home in Washington, D.C., of hypertensive, atherosclerotic heart problems, in response to his partner, Gregory Nevins.

As previously reported, Baker was an early supporter for people living with HIV and AIDS within the Nineteen Eighties, when misinformation and fear-mongering in regards to the disease were rampant.

According to Douglas M. Brooks, director of the Office of National AIDS Policy under President Obama, it was Baker’s Christian faith that guided him toward compassion for others.

“He was very kind, very warm and inclusive – his circles, both professional and personal, were the most diverse I have ever seen, and he was guided by his Christian values,” Brooks told the outlet. “His ferocity was on display when people were marginalized, rejected or forgotten.”

In 1995, when he was executive director of the National AIDS Association, Baker pushed for June 27 to be designated National HIV Testing Day.

In 2012, he later wrote on the web site of the Global Health Advisor for which he was a technical advisor that: “These efforts were intended to help reduce the stigma associated with HIV testing and normalize it as part of regular screening.”

https://twitter.com/NBJContheMove/status/1856725113967632663?s=19

Baker also feared that men like himself, black gay men, and other men from marginalized communities were disproportionately affected by HIV and AIDS.

Baker pressured the Clinton administration to incorporate black and Latino people in clinical drug trials, and in 1994 he pointedly told the Clinton administration that he was bored with hearing guarantees but seeing no motion.

According to Lambda Legal CEO Kevin Jennings, yes that daring attitude that defines Baker’s legacy in the world of ​​HIV/AIDS promotion.

“Cornelius was a legendary leader in the fight for equality for LGBTQ+ people and all people living with HIV,” Jennings said in a press release. “In the more than twenty years that I knew him, I was continually impressed not only by how effective he was as a leader, but also by how he managed to strike the balance between being fierce and kind at the same time. His loss is devastating.”

Jennings continued: “Cornelius’ leadership can’t be overstated. For many years, he was one in all the nation’s leading HIV/AIDS warriors, working locally, nationally and internationally. No matter where he went, he proudly supported the HIV/AIDS community from the Nineteen Eighties until his death, serving in various positions including the Department of Health and Human Services, the National Association of Persons with Disabilities AIDS, and the Whitman-Walker Clinic . Jennings explained.

Jennings concluded: “His career also included several honors, including being the first recipient of the American Foundation for AIDS Research Foundation’s organization-building Courage Award. Our communities have lost a pillar in Cornelius, and as we mourn his death, we will be forever grateful for his decades of service to the community.”

Kaye Hayes, deputy assistant secretary for communicable diseases and director of the Office of Infectious Diseases and HIV/AIDS Policy, in her comment about his legacy, she called Baker “the North Star.”.

“It is difficult to overstate the impact his loss had on public health, the HIV/AIDS community or the place he held in my heart personally,” Hayes told Hiv.gov. “He was pushing us, charging us, pulling us, pushing us. With his unwavering commitment to the HIV movement, he represented the north star, constructing coalitions across sectors and dealing with leaders across the political spectrum to deal with health disparities and advocate for access to HIV treatment and look after all. He said, “The work isn’t done, the charge is still there, move on – you know what you have to do.” It’s in my ear and in my heart in the case of this job.

Hayes added: “His death is a significant loss to the public health community and to the many others who benefited from Cornelius’ vigilance. His legacy will continue to inspire and motivate us all.”

Baker is survived by his mother, Shirley Baker; his partner Nevins, who can be senior counsel at Lambda Legal; his sisters Chandrika Baker, Nadine Wallace and Yavodka Bishop; in addition to his two brothers, Kareem and Roosevelt Dowdell; along with the larger HIV/AIDS advocacy community.


This article was originally published on : www.blackenterprise.com
Continue Reading

Health and Wellness

Bovaer is added to cow feed to reduce methane emissions. Does it pass into milk and meat? And is it harmful to humans?

Published

on

By

There are growing concerns in regards to the use of feed supplements, Bowar 10to reduce methane production in cows.

Bovaer 10 consists of silicon dioxide (mainly sand), propylene glycol (food stabilizer approved by Food Safety Australia New Zealand) and lively substance 3-nitrooxypropanol (3-NOP).

There has been an enormous amount of misinformation in regards to the safety of 3-NOP, with some milk from herds fed this additive being labeled “Frankenmilk”. Others feared it could get to humans through beef.

The most significant thing is that 3-NOP is secure. Let’s clear up some major misconceptions.

Why do we want to limit methane production?

In our attempts to limit global warming, we’ve placed the best emphasis on CO₂ because the major man-made greenhouse gas. But methane is also a greenhouse gas, and although we produce less of it, it is: a much stronger greenhouse gas than CO₂.

Agriculture is the largest a man-made source of methane. As cattle herds expand to meet our growing demand for meat and milk, reducing methane production from cows is a vital way to reduce greenhouse gas emissions.

There are several ways to do that. Stopping bacteria within the stomachs of cows that produce methane one approach is to produce methane.

The methane produced by cows and sheep doesn’t come from the animals themselves, but from the microbes living of their digestive systems. 3-NO stop the enzymes that perform the last step of methane synthesis in these microorganisms.

3-NOP is not the one compound tested as a feed additive. Australian product based on seaweed, Rumin8for instance, it is also in development. Saponins, soap-like chemicals present in plants, and essential oils as well has been examined.

However, 3-NOP is currently one of the popular effective treatments.

Nitrooxypropanol structure: red balls are oxygen, gray carbon, blue nitrogen and white hydrogen.
PubChem

But is not it poison?

There are concerns on social media that Bovaer is “poisoning our food.”

But, as we are saying in toxicology, it’s the dose that makes the poison. For example, arsenic is deadly 2–20 milligrams per kilogram of body weight.

In contrast, 3-NOP was not lethal on the doses utilized in safety studies, up to 600 mg 3-NOP per kg body weight. At a dose of 100 mg per kg body weight in rats, it didn’t cause any adversarial effects.

What about reproductive issues?

The effect of 3-NOP on the reproductive organs has generated numerous commentary.

Studies in rats and cows showed that doses of 300–500 mg per kg body weight caused: contraction of the ovaries and testicles.

In comparison, to achieve the identical exposure in humans, a 70 kg human would want to eat 21–35 grams (about 2 tablespoons) of pure 3-NOP every day for a lot of weeks to see this effect.

No human will likely be exposed to this amount because 3-NOP doesn’t pass into milk – is fully metabolized within the cow’s intestines.

No cow will likely be exposed to these levels either.

The cow licks itself
Cows will not be exposed to levels tested on animals in laboratory studies.
Ground photo/Shutterstock

What about cancer?

3-NOP is not genotoxic or mutagenicwhich implies it cannot damage DNA. Thus, the results of 3-NOP are dose-limited, meaning that small doses will not be harmful, while very high doses are (unlike radiation where there is no secure dose).

Scientists found that at a dose of 300 mg per kilogram of body weight benign tumors of the small intestine of female ratsbut not male rats, after 2 years of every day consumption. At a dose of 100 mg 3-NOP per kg body weight, no tumors were observed.

Cows eat lower than 2 grams of Bovaer 10 per day (of which only 10% or 0.2 grams is 3-NOP). This is about 1,000 times lower than the appropriate every day intake 1 mg 3-NOP per kg body weight per day for a cow weighing 450 kg.

This level of consumption will likely be not the result in cancer or any of them other adversarial effects.

So how much are people exposed to?

Milk and meat consumers will likely be exposed to zero 3-NOP. 3-NOP doesn’t penetrate milk and meat: is completely metabolized within the cow’s intestines.

Farmers could also be exposed to small amounts of the feed additive, and industrial employees producing 3-NOP will potentially be exposed to larger amounts. Farmers and industrial employees already wear personal protective equipment to reduce exposure to other agricultural chemicals – and it is advisable to do that with Bovear 10 as well.

Milk
3-NOP doesn’t penetrate milk and meat.
Shutterstock

How widely has it been tested?

3-NOP has been in development for 15 years and has been subject to multiple reviews by European Food Safety Authority, UK Food Safety Authority AND others.

It has been extensively tested over months of exposure to cattle and has produced no unintended effects. Some studies actually say so improves the standard of milk and meat.

Bovaer was approved for use in dairy cattle by the European Union from 2022 and Japan in 2024. It is also utilized in many other countries, including: in beef products, amongst others Australia.

A really small amount of 3-NOP enters the environment (lower than 0.2% of the dose taken), no accumulates and is easily decomposed subsequently, it doesn’t pose a threat to the environment.

Since humans will not be exposed to 3-NOP through milk and meat, long-term exposure is not an issue.

What does Bill Gates have to do with this?

Bill Gates has invested in a distinct feed processing method for methane, Australian seaweed-based Rumin8. But he has nothing to do with Bovaer 10.

The Bill & Melinda Gates Foundation awarded research grants to the corporate producing 3-NOP for malaria control researchnot for 3-NOP.

The bottom line is that adding 3-NOP to animal feed doesn’t pose any risk to consumers, animals or the environment.

This article was originally published on : theconversation.com
Continue Reading
Advertisement

OUR NEWSLETTER

Subscribe Us To Receive Our Latest News Directly In Your Inbox!

We don’t spam! Read our privacy policy for more info.

Trending